To offer some balance, the critical difference here is the refinement the system offers. In particular the number of pathogens and the speed at which GSS products can detect compared with other similar systems. For example, GSS' Easy Screen product can detect up to 22 types of pathogens in the one test in only 4-5 hours. That's 1000% more than other similar products according to GSS CEO. Don't forget that they also have government funding to implement product in the fight against Ebola. GSS sold 37 000 kits last FY. I maintain my view that this is a good long term buy. DYOR.
To offer some balance, the critical difference here is the...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
68.0¢ |
Change
0.005(0.74%) |
Mkt cap ! $155.4M | |||
| Open | High | Low | Value | Volume |
| 70.0¢ | 70.0¢ | 67.5¢ | $16.68K | 24.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27724 | 67.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 70.0¢ | 15574 | 2 |
View Market Depth
| Last trade - 14.24pm 03/12/2024 (20 minute delay) ? |
| GSS (ASX) Chart |
